Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.21

SEK

2.79

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.21

SEK

2.79

percent

Future-proof Healthcare

One of our founders, Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Press release

2024/03/13

Strong ASTar results presented at AMCLI

Press release

2024/03/05

Q-linea participates in tender for rapid AST

Regulatory press release

2024/02/27

Year-end report 1 January – 31 December 2023
ASTar installed at two prominent US hospitalsFourth quarter: 1 October–31 December 2023Net sales amounted to SEK 0.1 million (0).The…
Read more >

Keep up to date – subscribe

Christer Samuelsson

Investor Relations

Phone: +46 18 444 36 10

Mobile: +46 70 600 15 20

christer.samuelsson@qlinea.com

. . .
The share

Information about Q-linea stock price and trading volume